Eris Lifesciences Ltd - 540596 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report29-05-2024
29-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING28-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript28-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares pursuant to ESOP Scheme 202124-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING22-05-2024
Eris Lifesciences Q4 Results Review - Healthy Execution, Addition Of Business Drive The Quarter: Motilal Oswal
Efforts towards integrating the acquired business and reduce debt22-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of Earnings Call21-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation21-05-2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Issue of Securities
Issue of Securities21-05-2024
Eris Lifesciences Ltd - 540596 - Financial Results For Quarter And Year Ended 31St March 2024
Financial Results for quarter and year ended 31st March 202421-05-2024